Academic

Stephanie Adams, OD, PhD

Assistant Professor

Email:

Phone:

312-949-7828

Why ICO?

As a new faculty member at ICO, I have been warmly received by all faculty and staff. I’m impressed with the collaborative research projects at ICO, and find the students are very talented. The eye exam at the IEI considers the entire patient from glasses prescription, to binocular vision function, to systemic disease - creating very strong student clinicians.

Biography

After earning a bachelor's degree at the University of Central Florida, Dr. Adams obtained her OD/PhD dual degree through New England College of Optometry and Boston University, conducting research on the protein expression of novel genetic associations with late-onset Alzheimer’s disease. With an interest in ocular pathology, Dr. Adams completed a residency at the West Roxbury Boston VA Hospital. She then joined ICO as an assistant professor and clinical faculty member.

Special Interests

Ocular disease, neurodegenerative disease

Education

University of Central Florida B.S

New England College of Optometry OD

Boston University PhD

West Roxbury VA Boston Healthcare System, Ocular Disease Residency

Experience

2019-present Illinois College of Optometry

2018-2019 West Roxbury Hospital VA Boston

Awards & Honors

The National Association of VA Optometrists (NAVAO) Resident Scholarship, 2018

Professional Organizations

American Academy of Optometry, member

Illinois Optometric Association, member

Publications

Journal of Alzheimer’s Disease 2019;68(1):357-365. doi: 10.3233/JAD-180977. Methionine Sulfoxide Reductase-B3 risk allele implicated in Alzheimer’s disease increases odds for brain infarcts. Sarah C. Conner, Laurent Benayoun, Jayandra Himali PhD, Stephanie L. Adams PhD, Qiong Yang, Charles DeCarli MD, Jan Blusztajn, PhD, Alexa Beiser PhD, Sudha Seshadri, MD, and Ivana Delalle, MD, PhD

Journal of Alzheimer’s Disease 2018; 63 (4): 1433-43. doi: 10.3233/JAD-171065. Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer’s Disease. Stephanie L. Adams, Laurent Benayoun, Kathy Tilton, Tiffany Mellott, PhD, Sudha Seshadri, MD, Jan Krzysztof Blusztajn, PhD, and Ivana Delalle, MD, PhD

Journal of Alzheimer’s Disease 2017; 60 (1): 43-56. doi: 10.3233/JAD-170459. Methionine sulfoxide reductase-B3 (MsrB3) protein associates with synaptic vesicles and its expression changes in the hippocampi of Alzheimer’s disease patients. Stephanie L. Adams, Laurent Benayoun, Kathy Tilton, Olivia R. Chavez, MS, Jayandra J. Himali, PhD, Jan Krzysztof Blusztajn, PhD, Sudha Seshadri, MD, and Ivana Delalle, MD, PhD

Journal of Neuropathology & Experimental Neurology 2016, 75 (8) 779-790. Subcellular Changes in Bridging Integrator 1 Protein Expression in the Cerebral Cortex During the Progression of Alzheimer Disease Pathology. Stephanie L. Adams, Kathy Tilton, James Kozubek MS, Sudha Seshadri MD, Ivana Delalle, MD PhD.